Quick Results for Quick Decisions

Your Emergency Pocket Lab

New Possibilities for Acute Care

Fepod is transforming acute care diagnostics with a portable, fingerprick-based platform that delivers lab-quality results in just a few minutes – directly at the patient’s side, in ambulances, emergency rooms, and critical care. Our technology combines a mobile phone, a pocket-sized reader, and disposable electrochemical test strips to make rapid, life-saving decisions possible.

Our first products target the most critical needs in acute care, starting with paracetamol testing, with additional tests in development. By 2030, Fepod’s goal is to become the #1 provider of acute care point-of-care diagnostics worldwide.

Member of the Mayo Clinic Innovation Exchange

Our Solution

Fast
Sampling

Simple, fast and relatively painless fingerprick sampling on our patented test strip.

Pocket-Sized
Device

Test strip is inserted in a pocket-sized device connected to a mobile phone.

Quick
Results

The results are available in just a couple minutes and transferred securely to central cloud for analysis.

Data Analysis

Our smart algorithm processes the data and returns the result to the user.

Join Us in Revolutionizing Blood Analytics

Become a distributor

See It in Action

Business Model

Fepod develops proprietary sensors for acute care diagnostics while also offering white-label solutions. Our focus is on POC testing in emergency medicine, toxicology, and critical care, where rapid diagnostics improve patient outcomes.

We sell disposable sensors and reader devices through distributor networks, targeting hospitals, ambulances, ICUs, and emergency departments. Leveraging an extensive subcontractor network, we ensure cost efficiency, scalability, and accelerated market penetration in high-impact acute care settings.

Clinical Studies and Research

Research Use Only Study

We are currently evaluating our sensors in an ongoing Research Use Only study at Turku Uni...

Read more

Early Clinical
Study #2

In the second study published in 2025, we analyzed close to 100 samples from patients with...

Read more

Early Clinical
Study #1

Our prototype sensors were validated in a small-scale human study in 2023. In this study, ...

Read more

Investors
and Careers

After several years of development at Aalto University supported by Business Finland’s R2B funding, Fepod Oy Ltd was incorporated in February 2022. Since then, the company has built an ISO 13485 -certified quality system, advanced its electrochemical point-of-care diagnostics platform into clinical evaluation, and expanded its pipeline to address critical acute-care needs starting with paracetamol.

Backed by Almaral Oy as the lead investor and supported by a combination of private capital, public grants, and loans, Fepod is now focused on clinical validation, regulatory approvals, and first commercial launches in selected markets. With a strong technology foundation, deep clinical collaboration, and a clear path to acute-care adoption, Fepod is positioned to deliver meaningful impact for patients and healthcare systems – and long-term value for partners and investors.

We currently have a twelve-person experienced and accomplished team, advisors from Aalto University & Helsinki University hospital and committed manufacturers for our readers and sensors.

For new recruits we’re offering a fast-growing, born global deep tech start-up that will make a difference in the diagnostics market. We are also reserving a notable option pool for our key recruits and for the board and advisors.

In Q1/24, we were accepted into the Mayo Clinic Innovation Exchange, underscoring our dedication to innovation in healthcare. Mayo Clinic Innovation Exchange was launched to provide premier medical and business insights, as well as the connections needed to bring breakthrough innovations to market.

Contact

Jussi
Pyysalo

Founder & CEO

jussi.pyysalo@fepod.com
+358 400 789 328

Niklas
Wester

Founder & CTO

niklas.wester@fepod.com

Elsi
Verrinder

Co-founder & CSO

elsi.verrinder@fepod.com

Antti
Rasi

Co-founder & CIO

antti.rasi@fepod.com

Mirka
Oksman

Quality & Regulatory Manager

mirka.oksman@fepod.com

Mikko
Laitila

Clinical Research Manager

mikko.laitila@fepod.com
+358 50 358 5956

Helena
Björndahl

Research Scientist

helena.bjorndahl@fepod.com

Klaara Kolehmainen

Research Scientist

klaara.kolehmainen@fepod.com

Aki Aittola

Research Scientist

aki.aittola@fepod.com

Tiina Iivanainen

Research Scientist

tiina.iivanainen@fepod.com

Linda Wederhorn

Software Developer & Quality Specialist

linda.wederhorn@fepod.com

Maria
Severina

Chairman of the Board

maria.severina@almaral.eu
+358 40 554 0127